研究者詳細 - 丸山　彰一

論文 - 丸山　彰一

分割表示 410 件中 201 - 220 件目／全件表示 >>

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (vol 22, pg 78, 2018) Open Access

Kato, H; Nangaku, M; Hirakata, H; Wada, T; Hayashi, T; Sato, H; Yamazaki, Y; Masaki, T; Kagimura, T; Yamamoto, H; Hase, H; Kamouchi, M; Imai, E; Mizuno, K; Iwasaki, M; Akizawa, T; Tsubakihara, Y; Maruyama, S; Narita, I

CLINICAL AND EXPERIMENTAL NEPHROLOGY 22 巻 ( 1 ) 頁： 85 - 86 2018年2月

Effect of dietary energy and polymorphisms in &ITBRAP&IT and &ITGHRL&IT on obesity and metabolic traits 査読有り

Imaizumi, T; Ando, M; Nakatochi, M; Yasuda, Y; Honda, H; Kuwatsuka, Y; Kato, S; Kondo, T; Iwata, M; Nakashima, T; Yasui, H; Takamatsu, H; Okajima, H; Yoshida, Y; Maruyama, S

OBESITY RESEARCH & CLINICAL PRACTICE 12 巻 ( 1 ) 頁： 39 - 48 2018年1月

Urinary and circulating levels of the anti-angiogenic isoform of vascular endothelial growth factor-A in patients with chronic kidney disease 査読有り

Kikuchi, R; Yasuda, Y; Nakatochi, M; Shibata, Y; Hara, T; Suzuki, A; Imaizumi, T; Suzuki, S; Ishii, H; Takeshita, K; Matsushita, T; Maruyama, S; Murohara, T

CLINICA CHIMICA ACTA 475 巻頁： 102 - 108 2017年12月

The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients 査読有り

Kaihan, AB; Yasuda, Y; Katsuno, T; Kato, S; Imaizumi, T; Ozeki, T; Hishida, M; Nagata, T; Ando, M; Tsuboi, N; Maruyama, S

CLINICAL AND EXPERIMENTAL NEPHROLOGY 21 巻 ( 6 ) 頁： 986 - 994 2017年12月

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome 査読有り Open Access

Saito, T; Iwano, M; Matsumoto, K; Mitarai, T; Yokoyama, H; Yorioka, N; Nishi, S; Yoshimura, A; Sato, H; Ogahara, S; Sasatomi, Y; Kataoka, Y; Ueda, S; Koyama, A; Maruyama, S; Nangaku, M; Imai, E; Matsuo, S; Tomino, Y

CLINICAL AND EXPERIMENTAL NEPHROLOGY 21 巻 ( 6 ) 頁： 961 - 970 2017年12月

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission 査読有り Open Access

Inagaki, K; Yasuda, Y; Ando, M; Kaihan, AB; Hachiya, A; Ozeki, T; Hishida, M; Imaizumi, T; Katsuno, T; Kato, S; Tsuboi, N; Maruyama, S

PLOS ONE 12 巻 ( 11 ) 頁： e0187607 2017年11月

Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers 査読有り Open Access

Kubo, Y; Imaizumi, T; Ando, M; Nakatochi, M; Yasuda, Y; Honda, H; Kuwatsuka, Y; Kato, S; Kikuchi, K; Kondo, T; Iwata, M; Nakashima, T; Yasui, H; Takamatsu, H; Okajima, H; Yoshida, Y; Maruyama, S

PLOS ONE 12 巻 ( 10 ) 頁： e0185476 2017年10月

Efficacy of urinary midkine as a biomarker in patients with acute kidney injury 査読有り Open Access

Hayashi, H; Sato, W; Kosugi, T; Nishimura, K; Sugiyama, D; Asano, N; Ikematsu, S; Komori, K; Nishiwaki, K; Kadomatsu, K; Matsuo, S; Maruyama, S; Yuzawa, Y

CLINICAL AND EXPERIMENTAL NEPHROLOGY 21 巻 ( 4 ) 頁： 597 - 607 2017年8月

Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients: Nagoya Health Navigator Study protocol 査読有り Open Access

Onoue, T; Goto, M; Kobayashi, T; Tominaga, T; Ando, M; Honda, H; Yoshida, Y; Tosaki, T; Yokoi, H; Kato, S; Maruyama, S; Arima, H

NAGOYA JOURNAL OF MEDICAL SCIENCE 79 巻 ( 3 ) 頁： 323 - 329 2017年8月

Mesangial proliferative glomerulonephritis in murine malaria parasite, Plasmodium chabaudi AS, infected NC mice 査読有り Open Access

Yashima, A; Mizuno, M; Yuzawa, Y; Shimada, K; Suzuki, N; Tawada, H; Sato, W; Tsuboi, N; Maruyama, S; Ito, Y; Matsuo, S; Ohno, T

CLINICAL AND EXPERIMENTAL NEPHROLOGY 21 巻 ( 4 ) 頁： 589 - 596 2017年8月

Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice 査読有り Open Access

Tomita, T; Arai, S; Kitada, K; Mizuno, M; Suzuki, Y; Sakata, F; Nakano, D; Hiramoto, E; Takei, Y; Maruyama, S; Nishiyama, A; Matsuo, S; Miyazaki, T; Ito, Y

SCIENTIFIC REPORTS 7 巻 ( 1 ) 頁： 6450 2017年7月

Long-term renal survival of γ3-heavy chain deposition disease: a case report 査読有り Open Access

Katsuno, T; Mizuno, S; Mabuchi, M; Tsuboi, N; Komatsuda, A; Maruyama, S

BMC NEPHROLOGY 18 巻 ( 1 ) 頁： 239 2017年7月

Association of interactions between dietary salt consumption and hypertension-susceptibility genetic polymorphisms with blood pressure among Japanese male workers 査読有り

Imaizumi, T; Ando, M; Nakatochi, M; Maruyama, S; Yasuda, Y; Honda, H; Kuwatsuka, Y; Kato, S; Kondo, T; Iwata, M; Nakashima, T; Yasui, H; Takamatsu, H; Okajima, H; Yoshida, Y; Matsuo, S

CLINICAL AND EXPERIMENTAL NEPHROLOGY 21 巻 ( 3 ) 頁： 457 - 464 2017年6月

Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice 査読有り Open Access

Sakata, F; Ito, Y; Mizuno, M; Sawai, A; Suzuki, Y; Tomita, T; Tawada, M; Tanaka, A; Hirayama, A; Sagara, A; Wada, T; Maruyama, S; Soga, T; Matsuo, S; Imai, E; Takei, Y

LABORATORY INVESTIGATION 97 巻 ( 4 ) 頁： 432 - 446 2017年4月

Growth Factor Midkine Promotes T-Cell Activation through Nuclear Factor of Activated T Cells Signaling and Th1 Cell Differentiation in Lupus Nephritis 査読有り Open Access

Masuda, T; Maeda, K; Sato, W; Kosugi, T; Sato, Y; Kojima, H; Kato, N; Ishimoto, T; Tsuboi, N; Uchimura, K; Yuzawa, Y; Maruyama, S; Kadomatsu, K

AMERICAN JOURNAL OF PATHOLOGY 187 巻 ( 4 ) 頁： 740 - 751 2017年4月

Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab 査読有り

Yamaguchi, M; Hori, M; Hiroshi, N; Maruyama, S

THROMBOSIS RESEARCH 151 巻頁： 79 - 81 2017年3月

Complement component 5 promotes lethal thrombosis 査読有り Open Access

Mizuno, T; Yoshioka, K; Mizuno, M; Shimizu, M; Nagano, F; Okuda, T; Tsuboi, N; Maruyama, S; Nagamatsu, T; Imai, M

SCIENTIFIC REPORTS 7 巻頁： 42714 2017年2月

High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients 査読有り Open Access

Mizuno, M; Suzuki, Y; Higashide, K; Sei, Y; Iguchi, D; Sakata, F; Horie, M; Maruyama, S; Matsuo, S; Morgan, BP; Ito, Y

PLOS ONE 12 巻 ( 1 ) 頁： e0169111 2017年1月

The Type of Vascular Access and the Incidence of Mortality in Japanese Dialysis Patients 査読有り

Ozeki Toshikazu, Shimizu Hideaki, Fujita Yoshiro, Inaguma Daijo, Maruyama Shoichi, Ohyama Yukako, Minatoguchi Shun, Murai Yukari, Terashita Maho, Tagaya Tomoki

Internal Medicine 56 巻 ( 5 ) 頁： 481 - 485 2017年

記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：The Japanese Society of Internal Medicine

Objective The National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) guidelines have recommended the use of arteriovenous fistula (AVF) at the initiation of dialysis. However, there are significant differences in the dialysis environments of Japan and the United States, and there are few people who receive hemodialysis via a central venous catheter (CVC) in Japan. The aim of the present study was to examine the association between the type of vascular access at the initiation of dialysis and the incidence of mortality in Japan. Methods This study was a prospective, multicenter, cohort study. The data was collected by the Aichi Cohort study of Prognosis in Patients newly initiated into dialysis (AICOPP) in which 18 Japanese tertiary care centers participated. The present study enrolled 1,524 patients who were newly introduced to dialysis (the patients started maintenance dialysis between October 2011 and September 2013). After excluding 183 patients with missing data, 1,341 patients were enrolled. The Cox proportional hazards model was used to evaluate mortality based on the type of vascular access. The types of vascular access were divided into four categories: AVF, arteriovenous graft (AVG), CVC changed to AVF during the course (CAVF), CVC changed to AVG during the course (CAVG). Results A multivariate analysis revealed that AVG, CAVF and CAVG were associated with a higher risk of mortality in comparison to AVF [hazard ratio (HR), 1.60; p=0.048; HR, 2.26; p=0.003; and HR, 2.45; p=0.001, respectively]. Conclusion The research proved that the survival rate among patients in whom hemodialysis was initiated with AVF was significantly higher than that in patients in whom hemodialysis was initiated with AVG or CVC.

DOI： 10.2169/internalmedicine.56.7563

Web of Science

PubMed

CiNii Research

Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience 査読有り

Katsuno Takayuki, Ozaki Takenori, Kim Hangsoo, Kato Noritoshi, Suzuki Yasuhiro, Akiyama Shinichi, Ishimoto Takuji, Kosugi Tomoki, Tsuboi Naotake, Ito Yasuhiko, Maruyama Shoichi

Intern Med 56 巻 ( 13 ) 頁： 1679 - 1686 2017年

担当区分：最終著者記述言語：英語掲載種別：研究論文（学術雑誌）出版者・発行元：The Japanese Society of Internal Medicine

To date, a recognized treatment for refractory membranous nephropathy (MN) has not been established. Recently, several reports have indicated the efficacy of rituximab as a novel treatment option. However, only a few published accounts exist of rituximab therapy for idiopathic MN (IMN) in the Asian population. We present the cases of three IMN patients who were treated with single-dose rituximab after they showed no response to conventional therapies, including corticosteroids, cyclosporine, cyclophosphamide, mizoribine, and mycophenolate mofetil. Although one case showed no response, a complete or incomplete remission was achieved in the other two cases. Rituximab may therefore be a beneficial treatment option for IMN.

DOI： 10.2169/internalmedicine.56.7908

<丸山 彰一>

論文 - 丸山 彰一

<丸山　彰一>

論文 - 丸山　彰一